Skip to main content
Log in

Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting

  • REVIEW ARTICLE
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

The treatment of nausea and vomiting in patients receiving high doses of irradiation and/or chemotherapeutic agents as preparation for hematopoietic stem cell transplantation is discussed. Such patients have very high rates of both early and delayed emesis. Based on the available evidence it is recommended that 5-HT3 receptor antagonists be used to combat emesis in this setting. Continued research is also required to define the optimal antiemetic strategy for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spitzer, T., Grunberg, S. & Dicato, M. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting. Support Care Cancer 6, 233–236 (1998). https://doi.org/10.1007/s005200050159

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005200050159

Navigation